Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J de Visser

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Drug Discovery Today|February 21, 2026
Tracing the path of non-industry-driven medicine development for rare diseases through regulatory interactions at the European Medicines AgencyNoa Rosenberg, Carla E M Hollak, V A Haverhoek, et al.
Journal of Low Temperature Physics|December 5, 2022
Model and Measurements of an Optical Stack for Broadband Visible to Near-Infrared Absorption in TiN MKIDsK Kouwenhoven, I Elwakil, J van Wingerden, et al.
Human Factors|February 2, 2017
A Little Anthropomorphism Goes a Long WayEwart J de Visser, Samuel S Monfort, Kimberly Goodyear, et al.
Journal of Experimental Psychology. Applied|August 10, 2016
Almost human: Anthropomorphism increases trust resilience in cognitive agentsEwart J de Visser, Samuel S Monfort, Ryan McKendrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2022
Spiritual over physical formidability determines willingness to fight and sacrifice through loyalty in cross-cultural populationsChad C Tossell, Angel Gómez, Ewart J de Visser, et al.
European Journal of Clinical Pharmacology|June 9, 2026
From authorisation to clinical practice: evolution of the use of biological medicines according to the SmPC and guidelines (2006 to 2025)B M F Penninx, C E M Hollak, S W Tas, et al.
Clinical Pharmacology and Therapeutics|October 19, 2002
Concentration-effect relationships of two rilmenidine single-dose infusion rates in hypertensive patientsSaco J de Visser, Jeroen-Paul van der Post, Loyd Nanhekhan, et al.
British Journal of Clinical Pharmacology|January 22, 2003
Biomarkers for the effects of benzodiazepines in healthy volunteersS J de Visser, J P van der Post, P P de Waal, et al.
Diabete & Metabolisme|July 1, 1990
Psychological impact of continuous subcutaneous insulin infusion pump therapy in non-selected newly diagnosed insulin dependent (type 1) diabetic children: evaluation after two years of therapyF M Slijper, C E De Beaufort, G J Bruining, et al.
Orphanet Journal of Rare Diseases|September 5, 2020
Registries for orphan drugs: generating evidence or marketing tools?Carla E M Hollak, Sandra Sirrs, Sibren van den Berg, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Drug Discovery Today|February 21, 2026
Tracing the path of non-industry-driven medicine development for rare diseases through regulatory interactions at the European Medicines AgencyNoa Rosenberg, Carla E M Hollak, V A Haverhoek, et al.
Journal of Low Temperature Physics|December 5, 2022
Model and Measurements of an Optical Stack for Broadband Visible to Near-Infrared Absorption in TiN MKIDsK Kouwenhoven, I Elwakil, J van Wingerden, et al.
Human Factors|February 2, 2017
A Little Anthropomorphism Goes a Long WayEwart J de Visser, Samuel S Monfort, Kimberly Goodyear, et al.
Journal of Experimental Psychology. Applied|August 10, 2016
Almost human: Anthropomorphism increases trust resilience in cognitive agentsEwart J de Visser, Samuel S Monfort, Ryan McKendrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2022
Spiritual over physical formidability determines willingness to fight and sacrifice through loyalty in cross-cultural populationsChad C Tossell, Angel Gómez, Ewart J de Visser, et al.
European Journal of Clinical Pharmacology|June 9, 2026
From authorisation to clinical practice: evolution of the use of biological medicines according to the SmPC and guidelines (2006 to 2025)B M F Penninx, C E M Hollak, S W Tas, et al.
Clinical Pharmacology and Therapeutics|October 19, 2002
Concentration-effect relationships of two rilmenidine single-dose infusion rates in hypertensive patientsSaco J de Visser, Jeroen-Paul van der Post, Loyd Nanhekhan, et al.
British Journal of Clinical Pharmacology|January 22, 2003
Biomarkers for the effects of benzodiazepines in healthy volunteersS J de Visser, J P van der Post, P P de Waal, et al.
Diabete & Metabolisme|July 1, 1990
Psychological impact of continuous subcutaneous insulin infusion pump therapy in non-selected newly diagnosed insulin dependent (type 1) diabetic children: evaluation after two years of therapyF M Slijper, C E De Beaufort, G J Bruining, et al.
Orphanet Journal of Rare Diseases|September 5, 2020
Registries for orphan drugs: generating evidence or marketing tools?Carla E M Hollak, Sandra Sirrs, Sibren van den Berg, et al.
Pageof 8